S40L (p.Ser40Leu) variant of DBH (Dopamine beta-hydroxylase)

S40L (p.Ser40Leu) in DBH (Dopamine beta-hydroxylase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

S40L (p.Ser40Leu) variant details